NCT02024464View on ClinicalTrials.gov

Comparing Hydrus Microstent(TM) to the iStent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery

NACompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2017

Study Completion Date

August 31, 2018

Conditions
Primary Open Angle GlaucomaPseudoexfoliative GlaucomaPigmentary Dispersion Glaucoma
Interventions
DEVICE

Hydrus Microstent

Device inserted into Schlemm's canal to enhance aqueous flow from the anterior chamber.

DEVICE

iStent Trabecular Micro Bypass

Device inserted into Schlemm's canal to enhance aqueous flow from the anterior chamber.

PROCEDURE

Cataract removal and intraocular lens (IOL) implantation

Cataract removal with phacoemulsification using standard techniques, followed by implantation with a posterior-chamber IOL suitable for glaucoma subjects

Sponsors

Lead Sponsor

Ivantis, Inc.
All Listed Sponsors
lead

Ivantis, Inc.

INDUSTRY